Syngene to expand operations with Rs 788 cr investment in Hyderabad Illustrative image – not actual.

Global contract research, development and manufacturing services firm Syngene plans to invest up to Rs 788 crore for expansion of its operations in Genome Valley, near Hyderabad.

The ground-breaking ceremony took place on 14 September, 2023, in which Industries and IT Minister K.T.Rama Rao and Secretary Jayesh Ranjan, the company’s non-executive chairperson Kiran Mazumdar Shaw, COO Mahesh Bhalgat and others participated.

The company has acquired 17 acres for the new research facilities, which primarily comprise laboratories for drug discovery. The development will total around 16.5 lakh sq. ft. built-up area. The construction is expected to begin in 2024, once the statutory approvals are obtained. The expanded campus would generate up to 1,000 jobs in science over the next five years.

Highlighting the opportunities the state provides, the aim is to facilitate necessary infrastructure and support systems to enable pioneering lifescience R&D activities, which will drive innovation and foster economic development, the Minister said.

The existing research facility of the company has expanded to two lakh sq. ft. housing more than 900 scientists, and focuses on discovery chemistry and biology, for the global pharmaceutical industry.

← All latest storiesBack to top →